Cardiovascular Revascularization Medicine
Volume 7, Issue 4 , Pages 217-221 , October 2006

Autologous bone marrow-derived progenitor cell myocardial delivery for recent myocardial infarction patients following early angioplasty: results from a pilot study

  • Maddury Jyotsna

      Affiliations

    • Cardiology Department, Nizam's Institute of Medical Sciences, Hyderabad, India
    • Corresponding Author InformationCorresponding author. Cardiology Department, Nizam's Institute of Medical Sciences, Punjagutta, Hyderabad, Andhra Pradesh, India. Tel.: +91 4027952277; fax: +91 4023310076.
    • ,
  • Geeta K. Vemuganti

      Affiliations

    • Stem Cell Laboratory, LV Prasad Eye Institute, Hyderabad, India
    • ,
  • Purushottam Reddy

      Affiliations

    • Stem Cell Laboratory, LV Prasad Eye Institute, Hyderabad, India
    • ,
  • K. Sarat Chandra

      Affiliations

    • Cardiology Department, Nizam's Institute of Medical Sciences, Hyderabad, India

Received 29 April 2006 ,Accepted 28 June 2006.

References 

  1. Strauer BE, Brehm M, Zeus T, Gattermann N, Hernandez A, Sorg RV, et al. Intracoronary, human autologous stem cell transplantation for myocardial regeneration following myocardial infarction. Dtsch Med Wochenschr. 2001;126:932–938
  2. Itescu S, Kocher AA, Schuster MD. Myocardial neovascularization by adult bone marrow-derived angioblasts: strategies for improvement of cardiomyocyte function. Heart Fail Rev. 2003;8:253–258
  3. Siminiak T, Grygielska B, Jerzykowska O, Fiszer D, Kalmucki P, Rzezniczak J, et al. Autologous bone marrow stem cell transplantation in acute myocardial infarction—report of two cases. Kardiol Pol. 2003;59:502–510
  4. Vulliet PR, Greeley M, Halloran SM, MacDonald KA, Kittleson MD. Intra-coronary arterial injection of mesenchymal stromal cells and microinfarction in dogs. Lancet. 2004;363:783–784
  5. Boyle AJ, Schuster M, Witkowski P, Xiang G, Seki T, Way K, et al. Additive effects of endothelial progenitor cells combined with ACE inhibition and beta-blockade on left ventricular function following acute myocardial infarction. J Renin Angiotensin Aldosterone Syst. 2005;6:33–37
  6. Orlic D. BM stem cells and cardiac repair: where do we stand in 2004?. Cytotherapy. 2005;7:3–15
  7. Buziashvili IuI, Matskeplishvili ST, Alekian BG, Aripov MA, Kamardinov DKh, Bokeriia LA. Acute coronary syndrome and cell technologies. Vestn Ross Akad Med Nauk. 2005;4:65–70
  8. Schwartz Y, Kornowski R. Autologous stem cells for functional myocardial repair. Heart Fail Rev. 2003;8:237–245
  9. Strauer BE, Kornowski R. Stem cell therapy in perspective. Circulation. 2003;107:929–934
  10. Obradovic S, Rusovic S, Balint B, Ristic-Andelkov A, Romanovic R, Baskot B, et al. Autologous bone marrow-derived progenitor cell transplantation for myocardial regeneration after acute infarction. Vojnosanit Pregl. 2004;61:519–529
  11. Chen SL, Fang WW, Qian J, Ye F, Liu YH, Shan SJ, et al. Improvement of cardiac function after transplantation of autologous bone marrow mesenchymal stem cells in patients with acute myocardial infarction. Chin Med J. 2005;118:88
  12. Wollert KC, Meyer GP, Lotz J, et al. Intracoronary autologous bone marrow cell transfer after myocardial infarction: the BOOST randomized controlled clinical trial. Lancet. 2004;364:141–148
  13. Wollert KC, Drexler H. Clinical applications of stem cells for the heart. Circ Res. 2005;96:151–163

☆ This work was funded by the Nizam's Institute of Medical Sciences (Hyderabad, India) and the LV Prasad Eye Institute.

☆☆ The authors do not have any commercial interest in any of the materials and methods used in this study.

PII: S1553-8389(06)00183-7

doi: 10.1016/j.carrev.2006.06.004

Cardiovascular Revascularization Medicine
Volume 7, Issue 4 , Pages 217-221 , October 2006

Article Tools

* Image Usage & Resolution